Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor

scientific article published in September 2003

Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2337/DIABETES.52.9.2403
P8608Fatcat IDrelease_y4fxv4infrhz3kzvddkyoxqma4
P698PubMed publication ID12941782
P5875ResearchGate publication ID10594700

P50authorCharles A StanleyQ56939652
P2093author name stringArupa Ganguly
Courtney MacMullen
Eduardo Ruchelli
Lydia Aguilar-Bryan
Ana Crane
Linda Steinkrauss
Paul S Thornton
P433issue9
P407language of work or nameEnglishQ1860
P304page(s)2403-2410
P577publication date2003-09-01
P1433published inDiabetesQ895262
P1476titleClinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor
P478volume52

Reverse relations

cites work (P2860)
Q37251122A mouse model of human hyperinsulinism produced by the E1506K mutation in the sulphonylurea receptor SUR1.
Q42455960A signaling role of glutamine in insulin secretion
Q44709067Assembly, maturation, and turnover of K(ATP) channel subunits
Q41676854Clinical and Genetic Characteristics, Management and Long-Term Follow-Up of Turkish Patients with Congenital Hyperinsulinism
Q30951393Clinical and molecular data from 61 Brazilian cases of Congenital Hyperinsulinemic Hypoglycemia
Q27865219Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations
Q51797847Complex ABCC8 DNA variations in congenital hyperinsulinism: lessons from functional studies.
Q43060176Congenital hyperinsulinism in Brazilian neonates: a study of histology, KATP channel genes, and proliferation of β cells
Q51261501Congenital hyperinsulinism: global and Japanese perspectives.
Q37422505Dominant form of congenital hyperinsulinism maps to HK1 region on 10q.
Q37302876Dominant versus recessive: molecular mechanisms in metabolic disease
Q37193748Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutations
Q35814384From pharmacogenetics to personalized medicine: a vital need for educating health professionals and the community
Q28301770Genetics of congenital hyperinsulinism
Q60922248High-frequency actionable pathogenic exome variants in an average-risk cohort
Q35201578Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations
Q26749617Hyperinsulinemic Hypoglycemia - The Molecular Mechanisms
Q52085176KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes.
Q36688366Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates
Q35711972Molecular defects in insulin secretion in type-2 diabetes
Q28292136Mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) in diabetes mellitus and hyperinsulinism
Q36756556Novel de novo mutation in sulfonylurea receptor 1 presenting as hyperinsulinism in infancy followed by overt diabetes in early adolescence
Q92974124Novel dominant KATP channel mutations in infants with congenital hyperinsulinism: Validation by in vitro expression studies and in vivo carrier phenotyping
Q50088043Nutrient sensing in pancreatic islets: lessons from congenital hyperinsulinism and monogenic diabetes
Q36482115PKA phosphorylation of SUR2B subunit underscores vascular KATP channel activation by beta-adrenergic receptors
Q46589358Pancreatic regeneration after near-total pancreatectomy in children with nesidioblastosis
Q27865195Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects
Q34104226Persistent hyperinsulinemic hypoglycemia of infancy: constitutive activation of the mTOR pathway with associated exocrine-islet transdifferentiation and therapeutic implications
Q64100352The Genetic and Molecular Mechanisms of Congenital Hyperinsulinism
Q57199759The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children
Q37522353The unusual stoichiometry of ADP activation of the KATP channel.
Q37259401Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism

Search more.